Orion S.A. (OEC) Dividend History

Orion S.A. (OEC) is a pharmaceutical company based in Greece, specializing in the development, manufacturing, and marketing of a range of pharmaceutical products. The company focuses on areas such as prescription medicines, over-the-counter (OTC) products, and generics, serving both domestic and international markets. Known for its commitment to innovation and quality, Orion has established a strong presence in the pharmaceutical industry in Southeastern Europe and beyond.

1700 City Plaza Drive, Suite 300, Spring, TX, 77389
Phone: (281) 381-2959
Website: https://www.orioncarbons.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
July 02, 2025	$0.02	06/11/2025	06/11/2025
April 04, 2025	$0.02	03/13/2025	03/13/2025
January 21, 2025	$0.02	12/13/2024	12/13/2024
October 09, 2024	$0.02	07/01/2024	07/01/2024
July 02, 2024	$0.02	06/11/2024	06/11/2024
April 04, 2024	$0.02	03/12/2024	03/13/2024
January 17, 2024	$0.02	12/14/2023	12/15/2023
October 05, 2023	$0.02	09/14/2023	09/15/2023
July 06, 2023	$0.02	05/16/2023	05/17/2023
April 05, 2023	$0.02	03/20/2023	03/21/2023
January 10, 2023	$0.02	12/30/2022	01/03/2023
October 04, 2022	$0.02	09/20/2022	09/21/2022
July 01, 2022	$0.02	06/21/2022	06/22/2022
April 06, 2022	$0.02	03/28/2022	03/29/2022
January 12, 2022	$0.02	01/04/2022	01/05/2022
March 31, 2020	$0.20	03/09/2020	03/10/2020
December 30, 2019	$0.20	12/17/2019	12/18/2019
September 30, 2019	$0.20	09/19/2019	09/20/2019
June 28, 2019	$0.20	06/19/2019	06/20/2019
March 29, 2019	$0.20	03/08/2019	03/11/2019
December 28, 2018	$0.20	12/17/2018	12/18/2018
September 28, 2018	$0.20	09/19/2018	09/20/2018
June 30, 2018	$0.20	06/19/2018	06/20/2018
March 29, 2018	$0.20	03/09/2018	03/12/2018
December 27, 2017	$0.20	12/21/2017	12/22/2017
June 30, 2017	$0.19	06/01/2017	06/05/2017
December 29, 2015	$0.19	12/23/2015	12/28/2015
September 24, 2015	$0.19	09/17/2015	09/21/2015
June 26, 2015	$0.17	06/18/2015	06/22/2015
April 20, 2015	$0.18	04/01/2015	04/06/2015
December 22, 2014	$0.83	12/12/2014	12/16/2014

Dividends Summary

Orion S.A. has issued 31 dividend payments over the past 11 years
The most recent dividend was paid 64 days ago, on April 4, 2025
The first recorded dividend was paid on December 22, 2014
The highest dividend payout was $0.83 per share
The average dividend over this 11 year span is $0.13 per share
Orion S.A. has decreased its dividend payments by 97.51% since 2014

Company News

Orionin yhteistyökumppani MSD laajentaa opevesostaatin kliinistä kehitysohjelmaa naisten syöpiin

Orion's partner MSD has expanded the clinical development program for opevesostat (MK-5684) to include clinical trials for the treatment of breast, endometrial, and ovarian cancers in women. MSD has exclusive worldwide rights to opevesostat, which was discovered and developed by Orion.

GlobeNewswire Inc.
Orion-konsernin osavuosikatsaus tammi–maaliskuu 2025

Orion's Q1 2025 revenue grew 14.9% to €354.6 million, and operating profit increased 39.1% to €77.9 million. The company maintained its full-year 2025 guidance, expecting revenue of €1,550-1,650 million and operating profit of €350-450 million.

GlobeNewswire Inc.
Lääketeollisuus luovutti hallitukselle arvolupauksen: miljarditason investoinnit vuoteen 2030 mennessä

The Finnish pharmaceutical industry has pledged to invest over 1 billion euros in Finland by 2030, with a focus on R&D and production. The industry sees healthcare and wellbeing as key drivers of economic growth and productivity in Finland.

GlobeNewswire Inc.
Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium in New York, featuring various companies discussing topics like pricing power, margin recovery, and the M&A environment.

GlobeNewswire Inc.

Featured Companies: ARQ AVD CBT CC KWR LAC MTX ROG RYAM SHW
Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide

Orion's partner Bayer has submitted an application in China for the use of darolutamide in combination with androgen deprivation therapy for the treatment of metastatic hormone-sensitive prostate cancer. This submission is based on positive results from a Phase III trial.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 20:35:40 UTC

Orion S.A. (OEC) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies